755034-30-1

Upstream product

• 3251-56-7 2-methoxy-4-nitrophenol 
• 76513-69-4 (2-trimethylethylsilylethoxy)methyl chloride 

Downstream Products

• 755034-31-2 3-methoxy-4-((2-(trimethylsilyl)ethoxy)methoxy)aniline 
• 1574538-22-9 3-(biphenyl-4-yloxy)-1-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)pyrrolidin-2-one 
• 1574538-23-0 3-(biphenyl-4-yloxy)-1-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)pyrrolidin-2-one 
• 1574538-21-8 (±)-3-(biphenyl-4-yloxy)-1-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)pyrrolidin-2-one 
• 1574541-68-6 (±)-3-(biphenyl-4-yloxy)-1-(4-hydroxy-3-methoxyphenyl)pyrrolidin-2-one 
• 1574541-67-5 (±)-3-(biphenyl-4-yloxy)-1-(3-methoxy-(4-((2-trimethylsilyl)ethoxy)methoxy)phenyl)pyrrolidin-2-one 
• 1574541-66-4 (±)-3-bromo-1-(3-methoxy-4-((2-(trimethylsilyl)ethoxy)methoxy)phenyl)pyrrolidin-2-one 
• 1574538-14-9 3-(4-cyclopropylphenoxy)-1-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)pyrrolidin-2-one 
• 1574538-13-8 (S)-3-(4-cyclopropylphenoxy)-1-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)pyrrolidin-2-one 
• 1574541-47-1 (R)-2-(4-(3-(4-cyclopropylphenoxy)-2-oxopyrrolidin-1-yl)-2-methoxyphenoxy)ethyl methanesulfonate 
• 1574541-46-0 2-(4-(3-(4-cyclopropylphenoxy)-2-oxopyrrolidin-1-yl)-2-methoxyphenoxy)ethyl methanesulfonate 
• 1574543-02-4 3-(4-cyclopropylphenoxy)-1-(4-(2-hydroxyethoxy)-3-methoxyphenyl)pyrrolidin-2-one 
• 1574543-00-2 3-(4-cyclopropylphenoxy)-1-(4-(2-hydroxyethoxy)-3-methoxyphenyl)pyrrolidin-2-one 
• 1574542-92-9 (±)-3-(4-cyclopropylphenoxy)-1-(4-(2-hydroxyethoxy)-3-methoxyphenyl)pyrrolidin-2-one 

Relevant academic research and scientific papers

PYRROLONE OR PYRROLIDINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are melanin concentrating hormone receptor-1 (MCHR1) antagonists which may be used as medicaments.

AZOLOPYRROLONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS

The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula (I) including all pharmaceutically acceptable salts and stereoisomers thereof: wherein A is a mo